Navigation Links
Dr. Gary M. Levin's Multiple Sclerosis Treatment Review and MS Research Revealed by SclerosisTreatment.com
Date:5/10/2013

Denver, Colorado (PRWEB) May 10, 2013

According to http://www.SclerosisTreatment.com researchers are looking at MS every conceivable way taught by medicine, and although the FDA has approved several drug-based treatments, there isn’t a permanent cure for the condition.

The Multiple Sclerosis Treatment by Dr. Gary M. Levin uses a “step-by-step method that rehabilitates your immune system and boosts your supporting body systems to rid it of all symptoms”. The keys are correct nutrition, healthy diet and potent herbs that empower the impacted immune system to act within normal parameters instead of wreaking havoc.

“No drug provides a cure for multiple sclerosis so it is important to have a variety of treatment options available for patients. Multiple sclerosis can impair movement, sensation, and thinking and have a profound impact on a person’s quality of life,” reads a statement by Russell Katz, M.D., director of the Division of Neurology Products in the FDA’s Center for Drug Evaluation and Research.

With that picture in mind, it is easy to understand why MS patients are appealed by natural treatments for MS, e-books that sell for a tiny fraction of a full-drug therapy that give the patient herbal therapies to manage their condition. Dr. Gary M. Levin is a longtime US doctor, with decades of experience in the treatment of MS patients. For most of that time he had treated patients using the same Multiple Sclerosis drugs recommended, but a personal experience introduced him to herbal therapy and alternative medicine, which following years of research and experimentation has ended in a Multiple Sclerosis Natural Treatment.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Scientists uncover multiple faces of deadly breast cancer
2. Experimental Pill for Multiple Sclerosis Shows Promise
3. Fish Oil Supplements Wont Help in Multiple Sclerosis: Study
4. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
5. Low-dose whole-body CT finds disease missed on standard imaging for patients with multiple myeloma
6. Multiple thought channels may help brain avoid traffic jams
7. Study shows benefit of new maintenance therapy for multiple myeloma
8. FDA Issues Multiple Sclerosis Drug Alert
9. Pot Might Help Ease Multiple Sclerosis Symptoms
10. Lenalidomide prolongs disease control for multiple myeloma patients after stem cell transplant
11. Multiple sclerosis patients have lower risk of cancer: UBC-VCH research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... Now that Thanksgiving is finally here ... Emassagechair.com has announced its eagerly awaited, once ... , Negotiating on behalf of their customers, and drawing ... Emassagechair.com has generated significant buzz in the industry with ... yet. , Shoppers are excited for significant savings available ...
(Date:11/27/2014)... “LAB.C” was featured on NewsWatch as part of its ... products available to consumers. Mallory Sofastaii, a technology expert and ... shared with viewers the company offers a cable case, iBed, ... love portability and functionality. A unique mobile company at ... and 5S has a portable USB charger built in. The ...
(Date:11/27/2014)... Philadelphia, PA (PRWEB) November 27, 2014 ... alongside volunteer Aria Health employees, prepared and donated ... to the Lutheran Settlement House , a non-profit, ... and families living in Philadelphia. The dinners were ... Settlement House Senior Center, and distributed to vulnerable ...
(Date:11/27/2014)... New Delhi, India (PRWEB) November 27, 2014 ... internet marketing company, has announced online reputation management ... after doing a comprehensive study about the world of ... Google, Bing, and Yahoo. , Ethane Web Technologies ... project. Instead, it first analyzes the project to reach ...
(Date:11/27/2014)... In addition to a new dessert recipe or family ... season and become educated about the warning signs of ... holidays may raise questions about the physical and cognitive ... ability can occur with age, serious memory problems are ... between normal aging and more serious problems can help ...
Breaking Medicine News(10 mins):Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 3Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 5
... Nurse Practitioner and herbalist announces her first product, Omyst™, a healing ... successfully tested on over 2,000 patients and has been clinically proven ... insect bites, stings and sutures. , ... New York, ...
... is committed to bringing new acai health product reviews to the masses ... available on the market today. , ... Green Bay, WI (PRWEB) November ... new acai health product reviews to the masses by providing accurate descriptions ...
... WARSAW, Ind., Nov. 6 Zimmer Holdings, Inc.,(NYSE: ... it has become the founding,supporter of a new ... provide funding for post-graduate orthopaedic fellowships and,residency programs, ... entity, called OMeGA Medical Grants Association LLC (OMeGA),will ...
... 6 Lumenis(R) Ltd. a global,developer, manufacturer and ... surgical and aesthetic applications,announced today that it will ... November 8th at the American Academy of Ophthalmology,(AAO) ... Lumenis, President and Chief Executive Officer stated:,"Lumenis is ...
... 6 The following was released today,by Dr. ... report from the U.S. Department of Veterans Affairs ... waste,mismanagement and inaction to disclosures of fraud, waste, ... Veterans Health,Care System (CTVHCS)., Inaction to these ...
... (Nasdaq: MBRK ), a pharmaceutical company focused ... three patents protecting Moxatag (amoxicillin,extended-release) Tablets, 775mg, were ... 2008, pursuant to Section 4 of Public Law ... MiddleBrook President & CEO John Thievon said, ...
Cached Medicine News:Health News:Nurse Practitioner Creates Healing Herbal First-aid Spray 2Health News:Nurse Practitioner Creates Healing Herbal First-aid Spray 3Health News:Acai Berry Health Foods Heightens Consumer Awareness of the Purple Miracle Berry 2Health News:Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education 2Health News:Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education 3Health News:Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA 2Health News:Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA 3Health News:Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA 4Health News:War Veterans With Traumatic Brain Injury Pay the Price of Waste at the VA, Says Dr. Robert Van Boven 2Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 2Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 3Health News:MiddleBrook Pharmaceuticals Announces Orange Book Listing of Moxatag(TM) Patents 4
(Date:11/26/2014)... LOVELAND, Colo. , Nov. 25, 2014   Heska ... ; "Heska" or the "Company"), a provider of advanced ... Dr. Robert Grieve , Executive Chair, will attend The ... 11, 2014. The one-on-one conference will be held at The ... IL from 8 a.m. to 2:30 p.m. Please ...
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen (NASDAQ: ... ) today announced that AMAGINE-2 TM , a pivotal, multi-arm ... than 1,800 patients with moderate-to-severe plaque psoriasis, met its primary ... placebo at week 12. Brodalumab 210 mg given every two ... to be superior to Stelara on the primary endpoint of ...
(Date:11/26/2014)... China , Nov. 26, 2014 / -- China Nepstar Chain ... "Company"), a leading retail drugstore chain in ... operated stores, today announced the appointment of Ms. ... Officer, effective immediately. Ms.Zhang has over ... joined Nepstar in March 1999. Prior to Ms. Zhang,s ...
Breaking Medicine Technology:Heska to Attend Benchmark Micro Cap Discovery Conference 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 2China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 3
... of treating upper extremity fractures with ... many studies. , ,Intramedullary nailing using ... offers the benefits of anatomic alignment, ... dissection and early rehabilitation of the ...
... An innovative new system to help you ... The system's one-piece design creates a ... enhances postoperative radiographic assessment. The slotted superior ... the central column and are flared outward ...
... The QuickSite model 1056K LV lead ... and to promote shorter procedure times, ... performance, and reliability., ,The QuickSite LV ... advanced left ventricular lead, including such ...
... The AIM Titanium Tibial Nail ... the mechanical failures of existing ... for tibial interlocking nails. It ... range of diameters and lengths ...
Medicine Products: